Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score

被引:6
|
作者
Marin-Romero, Samira [1 ]
Elias-Hernandez, Teresa [1 ]
Isabel Asensio-Cruz, Maria [1 ]
Ortega-Rivera, Rocio [1 ]
Morillo-Guerrero, Raquel [2 ]
Toral, Javier [3 ]
Montero, Emilio [3 ]
Sanchez, Veronica [4 ]
Arellano, Elena [4 ]
Sanchez-Diaz, Jose Maria [1 ]
Real-Dominguez, Macarena [5 ]
Otero-Candelera, Remedios [1 ]
Jara-Palomares, Luis [1 ,6 ]
机构
[1] Hosp Univ Virgen Rocio, Unidad Med Quirurg Enfermedades Resp, Seville, Spain
[2] Hosp Ramon & Cajal, Serv Neumol, Madrid, Spain
[3] Hosp Univ Virgen Rocio, Unidad Urgencias & Emergencias, Seville, Spain
[4] Univ Seville, Hosp Univ Virgen Rocio, CSIC, Inst Biomed Sevilla IBiS, Seville, Spain
[5] Univ Malaga, Dept Med Prevent & Salud Publ, Malaga, Spain
[6] Inst Salud Carlos III, CIBERES, Madrid, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2019年 / 55卷 / 12期
关键词
Decision support techniques; Venous thromboembolism; Validation studies (Publication type); Pulmonary embolism; Venous thrombosis; ACUTE PULMONARY-EMBOLISM; ANTITHROMBOTIC THERAPY; DIAGNOSIS; THROMBOSIS; DURATION; RATES; RULE; COHORT; MODEL;
D O I
10.1016/j.arbres.2019.03.025
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Scales for predicting venous thromboembolism (VTE) recurrence are useful for deciding the duration of the anticoagulant treatment. Although there are several scales, the most appropriate for our setting has not been identified. For this reason, we aimed to validate the DASH prediction score and the Vienna nomogram at 12 months. Methods: This was a retrospective study of unselected consecutive VTE patients seen between 2006 and 2014. We compared the ability of the DASH score and the Vienna nomogram to predict recurrences of VTE. The validation was performed by stratifying patients as low-risk or high-risk, according to each scale (discrimination) and comparing the observed recurrence with the expected rate (calibration). Results: Of 353 patients evaluated, 195 were analyzed, with an average age of 53.5 +/- 19 years. There were 21 recurrences in 1 year (10.8%, 95% CI: 6.8%-16%). According to the DASH score, 42% were classified as low risk, and the rate of VTE recurrence in this group was 4.9% (95% CI: 1.3%-12%) vs. the high-risk group that was 15% (95% CI: 9%-23%) (p < .05). According to the Vienna nomogram, 30% were classified as low risk, and the rate of VTE recurrence in the low risk group vs. the high risk group was 4.2% (95% CI:0.5%-14%) vs. 16.2% (95% CI: 9.9%-24.4%) (p < .05). Conclusions: Our study validates the DASH score and the Vienna nomogram in our population. The DASH prediction score may be the most advisable, both because of its simplicity and its ability to identify more low-risk patients than the Vienna nomogram (42% vs. 30%). (C) 2019 SEPAR. Published by Elsevier Espana. S.L.U. All rights reserved.
引用
收藏
页码:619 / 626
页数:8
相关论文
共 50 条
  • [21] The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study
    Kyrle, P. A.
    Kammer, M.
    Eischer, L.
    Weltermann, A.
    Minar, E.
    Hirschl, M.
    Heinze, G.
    Eichinger, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (12) : 2402 - 2409
  • [22] Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores
    van Es, Nick
    Wells, Philip S.
    Carrier, Marc
    THROMBOSIS RESEARCH, 2017, 152 : 52 - 60
  • [23] Management of patients with venous thromboembolism and a high recurrence risk estimated by the Vienna Prediction Model: a prospective cohort study
    Sinkovec, Hana
    Kyrle, Paul A.
    Eischer, Lisbeth
    Gressenberger, Paul
    Gary, Thomas
    Brodmann, Marianne
    Heinze, Georg
    Eichinger, Sabine
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2025, 9 (01)
  • [24] Nomogram prediction for the risk of venous thromboembolism in patients with lung cancer
    Haike Lei
    Dan Tao
    Ningning Zhang
    Mao Sun
    Lisi Sun
    Dingyi Yang
    Yong Jiang
    Wei Zhou
    Yue Xie
    Ying Wang
    Cancer Cell International, 23
  • [25] Risk of recurrence after discontinuing anticoagulation in patients with COVID-19associated venous thromboembolism: a prospective multicentre cohort study
    Jara-Palomares, Luis
    Bikdeli, Behnood
    Jimenez, David
    Muriel, Alfonso
    Demelo-Rodriguez, Pablo
    Moustafa, Fares
    Villalobos, Aurora
    Lopez-Miguel, Patricia
    Lopez-Jimenez, Luciano
    Otalora, Sonia
    Peris, Maria Luisa
    Amado, Cristina
    Chopard, Romain
    Rivera-Civico, Francisco
    Monreal, Manuel
    ECLINICALMEDICINE, 2024, 73
  • [26] Should D-dimer testing be used to predict the risk of recurrence after discontinuation of anticoagulant therapy for a first unprovoked episode of venous thromboembolism?
    Wu, Cynthia
    Bates, Shannon M.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (04): : 225 - 229
  • [27] External Validation of Risk Scores for Predicting Venous Thromboembolism in Ambulatory Patients with Lung Cancer
    Yan, Ann-Rong
    Yip, Desmond
    Peterson, Gregory M.
    Samarawickrema, Indira
    Naunton, Mark
    Newman, Phillip
    Mortazavi, Reza
    CANCERS, 2024, 16 (18)
  • [28] Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism
    Antonio Nieto, Jose
    Solano, Rosario
    Trapero Iglesias, Natacha
    Ruiz-Gimenez, Nuria
    Fernandez-Capitan, Carmen
    Valero, Beatriz
    Tiberio, Gregorio
    Bura-Riviere, Alessandra
    Monreal, Manuel
    THROMBOSIS RESEARCH, 2013, 132 (02) : 175 - 179
  • [29] Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
    Rupa-Matysek, Joanna
    Gil, Lidia
    Kazmierczak, Maciej
    Baranska, Marta
    Komarnicki, Mieczyslaw
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [30] Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study
    Kearon, Clive
    Parpia, Sameer
    Spencer, Frederick A.
    Schulman, Sam
    Stevens, Scott M.
    Shah, Vinay
    Bauer, Kenneth A.
    Douketis, James D.
    Lentz, Steven R.
    Kessler, Craig M.
    Connors, Jean M.
    Ginsberg, Jeffrey S.
    Spadafora, Luciana
    Julian, Jim A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (07) : 1144 - 1152